Leading a Horse to Water

Facilitating Registration and Use of a Prescription Drug Monitoring Program

Richard (Rick) Deyo, Jessica M. Irvine, Sara E. Hallvik, Christi Hildebran, Todd Beran, Lisa M. Millet, Miguel Marino

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

OBJECTIVES:: Prescription Drug Monitoring Programs (PDMPs) can help inform patient management, coordinate care, and identify drug safety risks, abuse, or diversion. However, many clinicians are not registered to use these systems, and use may be suboptimal. We sought to describe outreach efforts in one state (Oregon); quantify uptake of system use; identify barriers; and identify potential system improvements.

METHODS:: Program reports of outreach efforts and operational metrics provided rates of registration and use. A statewide survey identified perceived barriers and potential improvements from users and non-users of the system.

RESULTS:: Even with extensive registration efforts, less than 25 percent of clinicians and pharmacists acquired PDMP accounts over 2 years of operation. Rapid increases in registration and use in 2013 corresponded to new requirements among large pharmacy chains that pharmacists register for and use the PDMP. Among surveyed PDMP non-users, nearly half were unaware they could register. Among users and non-users, over two-thirds indicated that time constraints were a major barrier and over half thought inability to delegate access was a major barrier. Desired improvements included linking state systems, faster entry of pharmacy data, and use of unique patient identifiers. Users also wanted better insurance coverage for mental health and addiction referrals.

DISCUSSION:: Increasing registration and use of PDMPs remains important. Clinician feedback indicates that program enhancements and healthcare system changes would facilitate using and responding to PDMP information. It appears premature to judge the efficacy of PDMPs until best practices for their use are identified and impacts are assessed.

Original languageEnglish (US)
JournalClinical Journal of Pain
DOIs
StateAccepted/In press - Nov 6 2014

Fingerprint

Prescription Drugs
Drug Monitoring
Horses
Water
Pharmacists
Patient Care Management
Insurance Coverage
Practice Guidelines
Mental Health
Referral and Consultation
Delivery of Health Care
Safety
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine
  • Clinical Neurology

Cite this

Leading a Horse to Water : Facilitating Registration and Use of a Prescription Drug Monitoring Program. / Deyo, Richard (Rick); Irvine, Jessica M.; Hallvik, Sara E.; Hildebran, Christi; Beran, Todd; Millet, Lisa M.; Marino, Miguel.

In: Clinical Journal of Pain, 06.11.2014.

Research output: Contribution to journalArticle

Deyo, Richard (Rick) ; Irvine, Jessica M. ; Hallvik, Sara E. ; Hildebran, Christi ; Beran, Todd ; Millet, Lisa M. ; Marino, Miguel. / Leading a Horse to Water : Facilitating Registration and Use of a Prescription Drug Monitoring Program. In: Clinical Journal of Pain. 2014.
@article{7b9c2e73473d4667866ed87c4f4604a7,
title = "Leading a Horse to Water: Facilitating Registration and Use of a Prescription Drug Monitoring Program",
abstract = "OBJECTIVES:: Prescription Drug Monitoring Programs (PDMPs) can help inform patient management, coordinate care, and identify drug safety risks, abuse, or diversion. However, many clinicians are not registered to use these systems, and use may be suboptimal. We sought to describe outreach efforts in one state (Oregon); quantify uptake of system use; identify barriers; and identify potential system improvements.METHODS:: Program reports of outreach efforts and operational metrics provided rates of registration and use. A statewide survey identified perceived barriers and potential improvements from users and non-users of the system.RESULTS:: Even with extensive registration efforts, less than 25 percent of clinicians and pharmacists acquired PDMP accounts over 2 years of operation. Rapid increases in registration and use in 2013 corresponded to new requirements among large pharmacy chains that pharmacists register for and use the PDMP. Among surveyed PDMP non-users, nearly half were unaware they could register. Among users and non-users, over two-thirds indicated that time constraints were a major barrier and over half thought inability to delegate access was a major barrier. Desired improvements included linking state systems, faster entry of pharmacy data, and use of unique patient identifiers. Users also wanted better insurance coverage for mental health and addiction referrals.DISCUSSION:: Increasing registration and use of PDMPs remains important. Clinician feedback indicates that program enhancements and healthcare system changes would facilitate using and responding to PDMP information. It appears premature to judge the efficacy of PDMPs until best practices for their use are identified and impacts are assessed.",
author = "Deyo, {Richard (Rick)} and Irvine, {Jessica M.} and Hallvik, {Sara E.} and Christi Hildebran and Todd Beran and Millet, {Lisa M.} and Miguel Marino",
year = "2014",
month = "11",
day = "6",
doi = "10.1097/AJP.0000000000000180",
language = "English (US)",
journal = "Clinical Journal of Pain",
issn = "0749-8047",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Leading a Horse to Water

T2 - Facilitating Registration and Use of a Prescription Drug Monitoring Program

AU - Deyo, Richard (Rick)

AU - Irvine, Jessica M.

AU - Hallvik, Sara E.

AU - Hildebran, Christi

AU - Beran, Todd

AU - Millet, Lisa M.

AU - Marino, Miguel

PY - 2014/11/6

Y1 - 2014/11/6

N2 - OBJECTIVES:: Prescription Drug Monitoring Programs (PDMPs) can help inform patient management, coordinate care, and identify drug safety risks, abuse, or diversion. However, many clinicians are not registered to use these systems, and use may be suboptimal. We sought to describe outreach efforts in one state (Oregon); quantify uptake of system use; identify barriers; and identify potential system improvements.METHODS:: Program reports of outreach efforts and operational metrics provided rates of registration and use. A statewide survey identified perceived barriers and potential improvements from users and non-users of the system.RESULTS:: Even with extensive registration efforts, less than 25 percent of clinicians and pharmacists acquired PDMP accounts over 2 years of operation. Rapid increases in registration and use in 2013 corresponded to new requirements among large pharmacy chains that pharmacists register for and use the PDMP. Among surveyed PDMP non-users, nearly half were unaware they could register. Among users and non-users, over two-thirds indicated that time constraints were a major barrier and over half thought inability to delegate access was a major barrier. Desired improvements included linking state systems, faster entry of pharmacy data, and use of unique patient identifiers. Users also wanted better insurance coverage for mental health and addiction referrals.DISCUSSION:: Increasing registration and use of PDMPs remains important. Clinician feedback indicates that program enhancements and healthcare system changes would facilitate using and responding to PDMP information. It appears premature to judge the efficacy of PDMPs until best practices for their use are identified and impacts are assessed.

AB - OBJECTIVES:: Prescription Drug Monitoring Programs (PDMPs) can help inform patient management, coordinate care, and identify drug safety risks, abuse, or diversion. However, many clinicians are not registered to use these systems, and use may be suboptimal. We sought to describe outreach efforts in one state (Oregon); quantify uptake of system use; identify barriers; and identify potential system improvements.METHODS:: Program reports of outreach efforts and operational metrics provided rates of registration and use. A statewide survey identified perceived barriers and potential improvements from users and non-users of the system.RESULTS:: Even with extensive registration efforts, less than 25 percent of clinicians and pharmacists acquired PDMP accounts over 2 years of operation. Rapid increases in registration and use in 2013 corresponded to new requirements among large pharmacy chains that pharmacists register for and use the PDMP. Among surveyed PDMP non-users, nearly half were unaware they could register. Among users and non-users, over two-thirds indicated that time constraints were a major barrier and over half thought inability to delegate access was a major barrier. Desired improvements included linking state systems, faster entry of pharmacy data, and use of unique patient identifiers. Users also wanted better insurance coverage for mental health and addiction referrals.DISCUSSION:: Increasing registration and use of PDMPs remains important. Clinician feedback indicates that program enhancements and healthcare system changes would facilitate using and responding to PDMP information. It appears premature to judge the efficacy of PDMPs until best practices for their use are identified and impacts are assessed.

UR - http://www.scopus.com/inward/record.url?scp=84912033588&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84912033588&partnerID=8YFLogxK

U2 - 10.1097/AJP.0000000000000180

DO - 10.1097/AJP.0000000000000180

M3 - Article

JO - Clinical Journal of Pain

JF - Clinical Journal of Pain

SN - 0749-8047

ER -